Shopping Cart
- Remove All
- Your shopping cart is currently empty
Nivocasan, also known as GS-9450 and LB-84451, a novel caspase-inhibitor has demonstrated hepatoprotective activity in fibrosis/apoptosis animal models. GS-9450 treatment induced significant reductions in ALT levels in NASH patients.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,970 | 1-2 weeks | |
50 mg | $2,580 | 1-2 weeks | |
100 mg | $3,400 | 1-2 weeks |
Description | Nivocasan, also known as GS-9450 and LB-84451, a novel caspase-inhibitor has demonstrated hepatoprotective activity in fibrosis/apoptosis animal models. GS-9450 treatment induced significant reductions in ALT levels in NASH patients. |
Molecular Weight | 415.41 |
Formula | C21H22FN3O5 |
Cas No. | 908253-63-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.